Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Recognition of reversible cardiomyopathies may aid targeted management; leaves open need for prospective trials to confirm strategies.
Cardiomyopathies (CMs) have many etiological factors that can result in severe structural and functional dysregulation. Fortunately, there are several potentially reversible CMs that are known to improve when the root etiological factor is addressed. In this article, we discuss several of these reversible CMs, including tachycardia-induced, peripartum, inflammatory, hyperthyroidism, Takotsubo, and chronic illness-induced CMs. Our discussion also includes a review on their respective pathophysiology, as well as possible management solutions.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: